Blog

Shahin Gharakhanian led the Program Committee and presented at the FACCNE Annual 2014 Life Sciences Event, 13 March 2014 @ the Genzyme Center, Cambridge MA.

April 6, 2014

The talk titled “New Initiatives in Academic Commercialization” highlights the University of Pennsylvania – UPenn – UPStart Program and the collaboration with NovoBioPharma a firm co-founded by Shahin Gharakhanian MD Consulting LLC. This is a new collaboration set up to provide innovative business and science solutions for academia-based early...

Continue reading »

InnaVirVax Press Release at CROI 2013

March 17, 2013

Shahin Gharakhanian statement in the latest Press Release from InnaVirVax issued during the Conference on Retroviruses, 3-6 March 2013, Atlanta GA, USA. Reference: Katlama Ch, Launay O, Ho Tsong Fang R, Bodilis H, Calin R, Autran B,  Gharakhanian S, Vieillard V, J Crouzet J, Debré P.  A randomized, placebo-controlled, double-blind, phase I/IIa...

Continue reading »

Potential role of anti-3S antibodies in an HIV medical cure strategy ?

February 4, 2013

Crouzet J, Vieillard V, Debré P, Katlama  C, Launay O, Ho Tsong Fang R, Desfontaines-Batéjat D, Marcu M, Gharakhanian  S. Potential role of anti-3S antibodies in an HIV medical cure strategy ?. Oral/Poster Presentation. HIV Cure & Eradication Workshop, 24-25 January 2013; Milan, Italy . [Poster: distinguished as best poster of the Workshop]. We...

Continue reading »